(858) 456-0820         info@cennabiosciences.com      


October 2018
Cenna is winner of 2019 Corporate Live Wire Innovation and Excellence award for most innovative company in Alzheimer's disease drug development
September 2018
NIH R44 Grant award to Dewji, Nazneen N./Cenna Biosciences Inc. Small molecule Therapeutics for Alzheimer's disease
August 2018
New Publication August 2018
Pharmacokinetics in Rat of P8, a Peptide Drug Candidate for the Treatment of Alzheimer's Disease: Stability and Delivery to the Brain
Dewji NN, Azar MR, Hanson LR, Frey II WH, Morimoto BH, Johnson D
June 2018
NIH R44 Grant award to Dewji, Nazneen N./ Cenna Biosciences Inc. Progressing the Preclinical Development of P8 for Alzheimer's disease